Schrodinger Inc’s filing revealed that its President of R&D, Therapeutics Akinsanya Karen unloaded Company’s shares for reported $0.42 million on Apr 14 ’25. In the deal valued at $25.09 per share,16,723 shares were sold. As a result of this transaction, Akinsanya Karen now holds 15,625 shares worth roughly $0.33 million.
Then, Karen Akinsanya bought 16,723 shares, generating $409,546 in total proceeds.
Before that, Herman Jenny sold 666 shares. Schrodinger Inc shares valued at $14,059 were divested by the SVP & Controller at a price of $21.11 per share. As a result of the transaction, Herman Jenny now holds 27,349 shares, worth roughly $0.57 million.
Leerink Partners initiated its Schrodinger Inc [SDGR] rating to an Outperform in a research note published on July 02, 2024; the price target was $29. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who began to cover the stock in early December with a ‘”an Overweight”‘ rating. Goldman started covering the stock on December 19, 2022. It rated SDGR as “a Neutral”.
Price Performance Review of SDGR
On Tuesday, Schrodinger Inc [NASDAQ:SDGR] saw its stock fall -1.51% to $20.88. Over the last five days, the stock has lost -20.09%. Schrodinger Inc shares have risen nearly 8.24% since the year began. Nevertheless, the stocks have fallen -1.60% over the past one year. While a 52-week high of $28.47 was reached on 02/18/25, a 52-week low of $16.60 was recorded on 04/07/25.
Levels Of Support And Resistance For SDGR Stock
The 24-hour chart illustrates a support level at 20.59, which if violated will result in even more drops to 20.31. On the upside, there is a resistance level at 21.39. A further resistance level may holdings at 21.91.
The most recent change occurred on March 01, 2022 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $55 price target.
